Αρχική World News A tribute to Professor Anne Charlton

A tribute to Professor Anne Charlton

Professor Anne Charlton fundraising for Cancer Research Campaign, one of the forerunners of Cancer Research UK.

Professor Anne Charlton was a much-loved colleague who blazed a research trail in cancer education and smoking prevention in schools.

Anne, who died in April aged 84 after contracting COVID-19, was a passionate advocate of the importance of public knowledge about cancer. She combined academic rigour with a down-to-earth and empathetic approach and her contribution to where we are today – in speaking in an open and informed manner about cancer and in driving down youth smoking rates – cannot be overstated.

Anne was a naturally inquisitive child, a trait that followed her throughout her life – from her early interest in botany research to her training and career as a biology teacher in schools in Barrow-in-Furness and Manchester.

It’s a testament to Anne’s energy and enthusiasm that she began her career in cancer research at the age of 39, focusing on cancer education, smoking prevention and the impact of cancer on children.

Cancer education

In 1974, Anne left teaching to take up a research post with the Manchester Regional Committee for Cancer Education. Cancer was still a taboo subject for many at this time, and the fear and misunderstanding it evoked often led to delays in seeking treatment.

With the first of many grants from Cancer Research Campaign, a forerunner of Cancer Research UK, Anne began to survey children’s and teachers’ opinions about cancer. The work led to a master’s degree and a lectureship at Manchester University and set Anne’s course for the next few decades.

Anne went on to explore the possibility of introducing cancer into the curriculum of secondary schools. This project opened up a whole new area of work and led to the development and rigorous evaluation of resources for schools, colleges and teachers – including teaching guides like ‘Cells, Cancers and Communities’ and the ‘Topic of Cancer’.

Through this work, hundreds if not thousands of teachers and education systems around the world were inspired to teach science to children in new ways. And it not only changed the conversation about cancer in schools, it also opened up discussions about smoking.

Children and smoking

By the early 1980s, Cancer Research Campaign (CRC) was beginning to fund research into young people and smoking, and Anne conducted a major survey of children and young people in northern England. The research provided a wealth of information about the factors that influence children to take up smoking, revealing that a quarter of 15-16 year-old girls were already regular smokers.

With further funding from CRC, Anne began to develop new approaches to teaching about cancer, health and tobacco to help delay uptake of smoking and support young smokers to quit.

Anne’s group developed and evaluated many resources for schools and teachers, including a smoking prevention programme for 9-10 year-old children, parents and teachers and a stop-smoking course for young people aged 15-19 years, which was based on the identification of 9 different types of smoker.

Her studies also highlighted external influences that reinforced children’s smoking, including tobacco industry sponsorship of Formula 1 racing and snooker, which contributed to the big push to transform UK government policy to de-normalise smoking.

Impact of cancer on children

With the rapid progress in treatment of many children’s cancers, increasing numbers of children were starting school for the first time or returning to the classroom after a cancer diagnosis.

Working closely with children’s cancer specialists at The Christie in Manchester, Anne initiated a detailed study of the experiences of a small group of children and their parents and teachers. This research revealed a number of physical, psychological and academic issues that could impact a child’s return to the classroom.

The success of this pilot led to a much larger study, which showed that teachers needed specific information about a child’s cancer, their treatment and the type of problems that might arise to fully support the child as they came back to school. Following on from this research, a resource for teachers, ‘Welcome back’, was developed by colleagues in Bristol and Exeter and widely distributed.

These are just a few examples of the many ways in which Anne’s work changed cancer education and conversations about young people and smoking. But her impact extended far beyond her research projects – she was not only a world-renowned expert in her field, she was also a mentor to many researchers, thanks to her undeniable strengths in communication and networking.

Her zest for living was irrepressible. She never retired, continuing to travel, publish and present her research, and to enjoy Shakespeare plays and flower shows to the end of her life.

A good friend and colleague to many, Anne was always ready to offer encouragement and support. She will be greatly missed.

Jean King, Cancer Research UK’s former director of tobacco control and Lesley Walker, Cancer Research UK’s former director of cancer information

More on this topic



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

EMA Recommends Granting a Conditional Marketing Authorisation for Autologous Anti-CD19-Transduced CD3+ Cells

On 15 October 2020, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...

New Treatment Helps Survivors Regain Sensation After Breast Cancer

When NBC’s Kristen Dahlgren was diagnosed with breast cancer, she didn’t think much about the lack of sensation that her mastectomy would likely leave...

Is there a future without Pap testing?

Maybe you saw the hashtag #DonutTakePAPAway on social media recently? ObGyn physicians and advocates are voicing their disagreement with the American Cancer Society’s (ACS)...

Mother Spent 14 Weeks Battling Breast Cancer Alone During COVID-19 Lockdown

Battling cancer is difficult for anyone, but it’s even harder when you have to do it alone. That’s what happened to Samantha Currie. Samantha, 27,...

ESMO 2020: New Treatments for Advanced Kidney Cancer, Prostate Cancer, and Bladder Cancer

The 2020 European Society for Medical Oncology (ESMO) Virtual Congress was held online from September 19 to September 21. In this podcast, Neeraj Agarwal,...

The UK Government’s spending review: Time to invest in the future of cancer care

This autumn, the chancellor Rishi Sunak will go to Parliament and set out the UK Government’s spending priorities in the Comprehensive Spending Review...